This story, ‘Nashville trials to start for new pneumonia vaccine’ originally ran on Nashville News Channel 5 on Aug. 12. You can see the video and read the story here. Pneumonia is a common illness, and Tennesseans may very well know someone who has had it. Now researchers are working on a new vaccine that […]
Nashville trials to start for new pneumonia vaccine Read More »
Pneumonia Vaccine Clinical Study Clinical Research Associates is now accepting new patients to a phase 3 clinical trial for pneumonia vaccines. You can join us if you meet eligible criteria by signing up here or by calling us at (615) 329-2222. Patients who complete the study will receive $355 in compensation. This study is for
New Study: Pneumonia Vaccine Clinical Trial Read More »
This essay, ‘Juneteenth Reminds us of Persisting Healthcare Inequities’ originally ran in The Tennessean’s Juneteenth essay series, which invited Black leaders and influencers to share their thoughts on lessons learned and lessons yet to be learned. Chardae Foster, clinical trials intern at Clinical Research Associates, Inc, contributed by sharing her family’s experience with cancer and
Juneteenth Reminds us of Persisting Healthcare Inequities Read More »
Are you thinking about signing up for a clinical trial? If so, you’ve come to the right place if you want to make an informed decision. Joining one can feel overwhelming at first, because there’s so much to learn. Our goal is to make the process easier to understand, so that you can make the
Clinical Trial Terms To Know Read More »
Nashville News Channel 4 recently spoke with Clinical Research Associates, Inc. patients in pediatric COVID vaccine trials, as well as an investigator in the clinical trial. The FDA will soon meet to discuss whether to authorize the vaccine for children ages 6 months to 5 years, and more data will be needed before then. Watch
Nashville News 4: Pediatric COVID Vaccine Trials Continue Read More »
Clinical Research Associates, Inc. is coordinating a clinical trial for investigational medicine that may help users stop smoking. The clinical trial sponsor, Achieve Life Sciences, issued a press release announcing signs of positive results in the study’s early phases. At CRA, inc., we will continue to enroll new patients in the trial to help continue
Stop-Smoking Clinical Trial Announces Positive Early Results Read More »
News Channel 5 in Nashville reporter Emily Luxen recently interviewed Clinical Research Associates, Inc. Medical Director Dr. Stephan Sharp about a new smoking cessation clinical trial in Nashville. You can read the full story below or where it originally ran on the NC5 website here. NASHVILLE, Tenn. (WTVF) — For those who started smoking during
Enrollment Open For Smoking Cessation Study in Nashville Read More »
Late last year, clinical investigator Dr. Michael Caldwell was speaking with a patient during a regularly scheduled visit to our clinic. The visit happened to coincide with an important anniversary for the Fisk Jubilee Singers, the famed group who earned Nashville the “Music City” moniker. Dr. Caldwell mentioned a concert at Nashville’s Ryman Auditorium that night,
How a Clinical Trial Uncovered a Piece of Musical History Read More »
Nashville News Channel 5 recently interviewed Clinical Research Associates, Inc. Medical Director Dr. Stephan Sharp to discuss our current clinical trials that may provide migraine relief to patients who suffer from migraines at least monthly. Read the story below and watch the video at the original link here. NASHVILLE, Tenn. (WTVF) — More than 35
Nashville Trial Looks to Find Migraine Relief for Sufferers – News Channel 5 Read More »
Nashville News 2 (WKRN) recently reported on our contributions to COVID vaccine research and pediatric clinical studies. See the story below for an interview with our medical director, Dr. Stephan Sharp, about why more families are needed so that we can continue to help study vaccines. NASHVILLE, Tenn. (WKRN) — A Pfizer vaccine for children
Children Needed for COVID Vaccine Research Read More »
